Received Oct 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | — |
Sick; did not feel good after the second one; 14Sep2021 was when she got the first shot / second dose was given on 19Nov2021; This is a spontaneous report received from a Consumer or other non HCP. A 57-year-old female patient received BNT162b2 (BNT162B2), on 19Nov2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "depressed" (unspecified if ongoing); "anxiety" (unspecified if ongoing). Concomitant medication(s) included: WELLBUTRIN; LEXAPRO; LORAZEPAM. Vaccination history included: Comirnaty (DOSE 1, SINGLE), administration date: 14Sep2021, for COVID-19 Immunization. The following information was reported: ILLNESS (hospitalization) with onset 2021, outcome "unknown", described as "Sick"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 19Nov2021, outcome "unknown", described as "14Sep2021 was when she got the first shot / second dose was given on 19Nov2021"; MALAISE (non-serious), outcome "unknown", described as "did not feel good after the second one". The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300015030 same patient, different vaccine dose number/event;US-PFIZER INC-202500198227 same patient, different vaccine dose number/event;
Medical History/Concurrent Conditions: Anxiety; Depression
WELLBUTRIN; LEXAPRO; LORAZEPAM